NCT01806324View on ClinicalTrials.gov

A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
HypertensionHyperlipidemia
Interventions
DRUG

HL040XC

single dose

DRUG

Losartan + Atorvastatin

Single dose

Trial Locations (1)

21201

Baltimore

Sponsors
All Listed Sponsors
lead

HanAll BioPharma Co., Ltd.

INDUSTRY